Episode

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1

Podcast: Hematologic Oncology Update
Published: Jul 27, 2026
Duration seconds: 1337
Processing state: not_requested
Canonical source: https://hematologic-oncology.captivate.fm/episode/5959-cllmicro2025-5mjc-1
Audio: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/bd9350d0-6b13-4d77-a236-0287422a9f82.mp3
JSON: /v1/public/podcasts/hematologic-oncology-update-916423/episodes/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-1
Markdown: /podcast/hematologic-oncology-update-916423/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-1.md

Actions

POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-1/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/hematologic-oncology-update-916423/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-1.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Featuring perspectives from Dr Mazyar Shadman, including the following topics: The CLL17 trial: Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia (CLL) (0:00) The AMPLIFY trial: Fixed-duration acalabrutinib combinations for untreated CLL (5:31) Zanubrutinib-based therapy for treatment-naïve CLL (12:32) CME information and select publications